甲状腺切除术后的低血症

Same author

Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs.

American journal of physiology. Cell physiology·2005

Same author

Life history of osteocytes: relationship to bone age, bone remodeling, and bone fragility.

Journal of musculoskeletal & neuronal interactions·2005

Same author

What is the normal rate of bone remodeling?

Bone·2004

Same author

The mineralization index--a new approach to the histomorphometric appraisal of osteomalacia.

Bone·2004

Same author

The attainment of peak bone mass: what is the relationship between muscle growth and bone growth?

Bone·2004

Same author

Large calcium fluxes that are not related to remodeling exist.

Bone·2003

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

相关实验视频

甲状腺切除术后的低血症

相关概念视频

Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs.

Life history of osteocytes: relationship to bone age, bone remodeling, and bone fragility.

What is the normal rate of bone remodeling?

The mineralization index--a new approach to the histomorphometric appraisal of osteomalacia.

The attainment of peak bone mass: what is the relationship between muscle growth and bone growth?

Large calcium fluxes that are not related to remodeling exist.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

相关实验视频

甲状腺切除术后的低血症

相关概念视频

相关文章

Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs.

Life history of osteocytes: relationship to bone age, bone remodeling, and bone fragility.

What is the normal rate of bone remodeling?

The mineralization index--a new approach to the histomorphometric appraisal of osteomalacia.

The attainment of peak bone mass: what is the relationship between muscle growth and bone growth?

Large calcium fluxes that are not related to remodeling exist.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.